<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Mechanisms of solute clearance and ultrafiltration in peritoneal dialysis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Mechanisms of solute clearance and ultrafiltration in peritoneal dialysis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Mechanisms of solute clearance and ultrafiltration in peritoneal dialysis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Madhukar Misra, MD, FRCP
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Ramesh Khanna, MD, FACP
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Thomas A Golper, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Eric N Taylor, MD, MSc, FASN
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 25, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chronic peritoneal dialysis (as with continuous ambulatory peritoneal dialysis [CAPD]) can be complicated by problems with either solute clearance (which occurs by solute diffusion from the plasma into dialysate) or ultrafiltration (which is driven by the osmotic gradient between the hyperosmotic dialysate and the plasma) [
         <a href="#rid1">
          1
         </a>
         ]. The mechanisms of solute clearance and ultrafiltration across the peritoneal membrane will be reviewed in this topic review. The clinical issues that can arise are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1973.html" rel="external">
          "Inadequate solute clearance in peritoneal dialysis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1914.html" rel="external">
          "Management of hypervolemia in patients on peritoneal dialysis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          GENERAL PRINCIPLES OF TRANSPORT ACROSS THE PERITONEAL MEMBRANE
         </span>
         <span class="headingEndMark">
          —
         </span>
         The average surface area of the peritoneal membrane is between 1 and 1.3 m
         <sup>
          2
         </sup>
         in adults [
         <a href="#rid2">
          2,3
         </a>
         ]. During peritoneal dialysis, it is principally the parietal peritoneum that participates in peritoneal transport since only approximately one-third of the visceral peritoneum is in contact with the dialysis solution at a given time [
         <a href="#rid4">
          4
         </a>
         ]. In addition to the capillary surface area, the diffusion length between the dialysate and the mesothelium also plays an important role in the overall transport characteristics of the peritoneum.
        </p>
        <p>
         There are three barriers between the dialysate in the peritoneum and capillary blood: the capillary wall, which is most important; the interstitium; and the mesothelial cell layer. The mesothelial cell layer does not constitute a major barrier to solute or water transport across the peritoneum, while the interstitium offers some resistance to solute transport that is mainly restricted to large solutes [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Pores for solute transport
         </span>
         <span class="headingEndMark">
          —
         </span>
         According to the three-pore model of solute transport, the capillary wall consists of a system of pores of three sizes, which are size selective in restricting solute transport [
         <a href="#rid6">
          6,7
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There is an abundance of small pores (average radius 40 to 50 Å) that mediate the transport of lower-molecular-weight solutes. The transport of these solutes is limited by the number of small pores.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The large pores constitute &lt;0.1 percent of the total number of pores but are much larger than the small pores (average radius &gt;150 Å). The radii of the smaller pores are constant, while the larger pores vary in size.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ultrasmall pores (3 to 5 Å), which constitute the third pore, are discussed in the next section.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h3">
          Aquaporin-1 and water transport
         </span>
         <span class="headingEndMark">
          —
         </span>
         The peritoneal membrane contains ultrasmall-pore water channels (3 to 5 Å), called aquaporin-1, which constitute the third pore in three-pore models of solute transport [
         <a href="#rid6">
          6,8-11
         </a>
         ]. This is the same water channel present in red blood cells and the proximal tubule in the kidney [
         <a href="#rid12">
          12
         </a>
         ] but different from aquaporin-2, which is the antidiuretic hormone-sensitive water channel in the collecting tubule [
         <a href="#rid13">
          13
         </a>
         ]. Aquaporin-1, which is permeable only to water, is present in the endothelial cells of the peritoneal microvasculature as the major water channel [
         <a href="#rid9">
          9,10
         </a>
         ]. Peritoneal tissue also contains small numbers of aquaporin-3 and aquaporin-4 [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
         The aquaporin system is responsible for transcellular water transport induced by the osmotic gradient created by adding hypertonic dialysate to the peritoneum. On average, it accounts for approximately 40 percent of total capillary ultrafiltration, with the remainder occurring via the paracellular route between the cells [
         <a href="#rid6">
          6,15
         </a>
         ]. As an example, cumulative ultrafiltration is reduced by approximately 50 to 60 percent in mice lacking the aquaporin-1 gene [
         <a href="#rid16">
          16,17
         </a>
         ]. By comparison, the absence of aquaporin-4 had no effect on osmotic water transport. Unlike aquaporin-mediated transport, which is primarily determined by the osmotic gradient, the small-pore water transport is dependent upon nonosmotic determinants [
         <a href="#rid18">
          18
         </a>
         ]. Aquaporin-1 may also be involved in vascular proliferation and leucocyte recruitment during inflammation [
         <a href="#rid19">
          19
         </a>
         ]. Preliminary in vivo evidence from a rat model of peritoneal dialysis suggests that it is possible to modulate the water transport function of aquaporin-1 by a pharmacologic agonist, such as AqF026 [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Solute transport
         </span>
         <span class="headingEndMark">
          —
         </span>
         Solute transport across the peritoneum occurs via diffusion down a favorable concentration gradient (eg, high blood urea concentration compared with none in the dialysate) or convection.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diffusion varies directly with the magnitude of the concentration gradient and inversely with the size of the solute.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Convection or solvent drag refers to solute transport that occurs with ultrafiltration (ie, water transport induced by an osmotic gradient), a process that is mediated by the frictional forces between water and solute. For any given solute, convection is measured by the sieving coefficient (S). S represents the ratio between the concentration of the solute in the ultrafiltrate and its concentration in the plasma, assuming that net diffusion is 0. On the other hand, the osmotic effectiveness of a solute against a membrane is measured by the reflection coefficient. The reflection coefficient (rc) varies from 0, if the membrane offers no resistance to transport of the solute, to 1, for an ideal semipermeable membrane that is completely impermeable to the solute. The relationship between these two parameters for an isoporous membrane is given by the equation: S = (1 - rc).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h3">
          Low-molecular-weight solutes
         </span>
         <span class="headingEndMark">
          —
         </span>
         The transport of low-molecular-weight solutes (eg, urea and creatinine) across the peritoneum primarily occurs by diffusion. This process is size selective (small solutes diffusing at faster rates than the larger solutes), and the rate is dependent upon the concentration gradient, peritoneal surface area, and peritoneal permeability. Peritoneal transport, at least in theory, may also be affected by other factors, such as vascular supply and the peritoneal charge. However, their overall contribution to solute transport is minimal at best.
        </p>
        <p>
         The size selectivity of the peritoneal membrane is often expressed by the term "restriction coefficient," in which a value of 1 implies absence of a size restriction barrier. Thus, the higher the value of the restriction coefficient, the lower the size-selective permeability of the peritoneum.
        </p>
        <p>
         The concept of mass transfer area coefficient (MTAC) represents the theoretical maximal peritoneal clearance by diffusion at time 0 (ie, before any solute transport has occurred). At this time, the concentration gradient across the membrane is at its highest and then progressively falls as solute diffuses from a compartment of high concentration to one of low concentration. In one of the simpler equations, small-solute transfer is supposed to follow first-order kinetics, with the contribution of convection assumed to be negligible [
         <a href="#rid21">
          21
         </a>
         ]:
        </p>
        <div class="formulaContainer">
         <div class="formula">
          <p>
           ln [(P - D0)  ÷  (P - Dt)]
           <br/>
           MTAC = (Vt/t)
          </p>
         </div>
        </div>
        <p>
         where Vt is the drained dialysate volume; t is the time; D0 and Dt are dialysate solute concentrations at start and at time t; and P is the plasma solute concentration.
        </p>
        <p>
         Modifications of this equation that correct for convection have been proposed [
         <a href="#rid22">
          22,23
         </a>
         ]. The calculation of MTAC, which is a research tool, is usually performed after a four- to six-hour dwell since inaccurate values may be obtained during shorter dwell times due to a large convective component and other factors. The relationship between the more commonly used D/P ratios (after a four-hour dwell)  (
         <a class="graphic graphic_figure graphicRef75224" href="/z/d/graphic/75224.html" rel="external">
          figure 1
         </a>
         ) and MTAC is generally linear. However, D/P values may overestimate or underestimate MTAC when the MTAC is very low or very high, respectively.
        </p>
        <p>
         Transport across the peritoneal membrane also occurs in the opposite direction, from the peritoneal cavity to the vascular compartment, via a process that is mainly diffusive and, therefore, size selective. This is particularly true of osmotic agents used in dialysis solutions such as glucose, glycerol, and amino acids. As an example, approximately 66 percent of the total instilled quantity of glucose is absorbed independent of the dialysate concentration used [
         <a href="#rid24">
          24
         </a>
         ]. For solutes with a higher molecular weight, this transport occurs via a combination of convection (predominantly through lymphatics) and transport to the peritoneal interstitium, via transmesothelial route (see
         <a class="local">
          'Fluid transport'
         </a>
         below). The relative proportion of convection to diffusion is 0.1 for a small molecule like glucose compared with 10 for a large molecule like Hb when administered intraperitoneally [
         <a href="#rid25">
          25,26
         </a>
         ].
        </p>
        <p>
         There is appreciable variation in the rate of solute transport among individuals as some are slow transporters, and approximately 15 percent are rapid transporters. It is now well appreciated that peritoneal dialysis patients have different peritoneal membrane transport characteristics. These differences are best classified and determined by use of the peritoneal equilibration test (PET)  (
         <a class="graphic graphic_figure graphicRef62604" href="/z/d/graphic/62604.html" rel="external">
          figure 2
         </a>
         ). Rapid transporters reach urea and creatinine equilibration more quickly, and the dialysate volume falls after two hours due to continuous reabsorption of fluid from the peritoneal cavity. (See
         <a class="medical medical_review" href="/z/d/html/1972.html" rel="external">
          "Peritoneal equilibration test"
         </a>
         .)
        </p>
        <p>
         The rate of low-molecular-weight solutes also varies with dialysate instilled volume, with increased clearance being observed with increased volume [
         <a href="#rid27">
          27
         </a>
         ]. By comparison, the clearance of beta-2 microglobulin, a middle-sized molecule, does not appear to change with changing instilled volume.
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          High-molecular-weight solutes
         </span>
         <span class="headingEndMark">
          —
         </span>
         Peritoneal transport of larger molecules occurs at a much slower rate. Thus, creatinine (mol wt 113) is slower than urea (mol wt 56), inulin (mol wt 5200) is slower than creatinine, and larger proteins cross the peritoneum very slowly  (
         <a class="graphic graphic_figure graphicRef75224" href="/z/d/graphic/75224.html" rel="external">
          figure 1
         </a>
         ). Proteins with higher molecular weights, such as albumin, transferrin, and immunoglobulin G (IgG), utilize the large pores described above for transport across the peritoneal membrane. The exact mode of this process is a subject of debate, but both size-selective diffusion and convection appear to contribute [
         <a href="#rid28">
          28
         </a>
         ]. Regardless of the mechanism, this process is sufficiently slow that serum proteins are present in low concentration in the dialysate, and equilibration with the plasma does not occur at clinically used dwell times. As a result, the clearance of these molecules approximates their MTAC.
        </p>
        <p>
         Both peritoneal permeability and the surface area of the peritoneal membrane influence the transfer of these larger solutes. The transport of these solutes out of the peritoneal cavity primarily occurs via the subdiaphragmatic lymphatics and, to a lesser degree, the peritoneal interstitium [
         <a href="#rid25">
          25,29
         </a>
         ]. This process is independent of molecular size [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h3">
          Electrolytes
         </span>
         <span class="headingEndMark">
          —
         </span>
         The transport of electrolytes, such as sodium, potassium, and bicarbonate, across the peritoneal membrane may have important therapeutic implications. The dialysate concentration of sodium shows a decline in the initial phase of a hypertonic dwell, followed by a gradual increase [
         <a href="#rid30">
          30,31
         </a>
         ]. The initial stage in this phenomenon, which is known as sodium sieving, results from selective transcellular water transport through ultrasmall, water-selective aquaporin-1 pores, lowering the dialysate sodium concentration by dilution [
         <a href="#rid32">
          32
         </a>
         ]. Thus, short exchanges with hypertonic dialysate can lead to hypernatremia [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p>
         The gradual rise in the dialysate sodium concentration in the latter phase of the dwell is due to diffusion of sodium from the circulation. The MTAC for sodium is 4 mL/min when hypertonic glucose (3.86 percent) is used as a dialysate [
         <a href="#rid34">
          34
         </a>
         ], while values of 9 mL/min have been reported for chloride [
         <a href="#rid35">
          35
         </a>
         ]. Despite having a lower molecular weight than urea (23 versus 60), the MTAC of sodium is significantly lower. Thus, sodium behaves as a larger molecule, probably due to hydration-induced alterations in its configuration. By comparison, the MTACs for urea and creatinine are approximately 16 and 9.4 mL/min/1.73 m
         <sup>
          2
         </sup>
         , respectively.
        </p>
        <p>
         The average MTAC for the clearance of potassium by diffusion is between 12 and 16 mL/min in patients on continuous ambulatory peritoneal dialysis (CAPD) [
         <a href="#rid34">
          34,35
         </a>
         ]. Potassium may also be released from the peritoneal lining, resulting in MTAC values as high as 24 mL/min during the first hour.
        </p>
        <p>
         Because of favorable concentration gradients, there is a net mass transfer of calcium and magnesium from the dialysate to the vascular compartment by diffusion. The standard dialysate concentrations of calcium and magnesium are 1.75 and 0.75 mmol/L, which are higher than the free (ie, unbound) concentrations in the plasma (1.25 and 0.55 mmol/L, respectively). When higher glucose concentrations are used, this net transfer is balanced by convective transport due to ultrafiltration [
         <a href="#rid36">
          36,37
         </a>
         ].
        </p>
        <p>
         The MTAC for bicarbonate (mol wt 61) is approximately 9.5 mL/min [
         <a href="#rid38">
          38
         </a>
         ]. Bicarbonate loss in peritoneal dialysis is dependent upon the plasma bicarbonate concentration (with lower values minimizing diffusion from plasma into the dialysate) and convective loss secondary to ultrafiltration. Standard dialysate contains lactate as a source of buffer at a concentration of 35 mmol/L. The use of standard dialysate results in an initial net diffusive and convective bicarbonate loss into the dialysate; this is counterbalanced by the movement of dialysate lactate into the blood as the subsequent metabolism of lactate generates bicarbonate [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p>
         The acid-base status of a patient on peritoneal dialysis is determined by the relationship between total metabolic acid production (a function of protein breakdown) and net loss or gain of base (bicarbonate loss versus lactate gain). An increase in the dose of dialysis (ie, increased number of exchanges) results in a net gain of lactate that can cause metabolic alkalosis. This phenomenon reflects maximum transfer of lactate during the initial part of the dwell, when the dialysate lactate concentration is at its highest.
        </p>
        <p>
         Similar principles apply to the acid-base status of patients using bicarbonate-based
         <a class="drug drug_general" data-topicid="113932" href="/z/d/drug information/113932.html" rel="external">
          peritoneal dialysis solutions
         </a>
         . In this setting, bicarbonate diffusion out of the dialysate is partially counterbalanced by convective bicarbonate loss into the dialysate.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Fluid transport
         </span>
         <span class="headingEndMark">
          —
         </span>
         Net transcapillary ultrafiltration (TCUF) is determined by the difference between the cumulative fluid transfer into the peritoneal cavity by ultrafiltration and the uptake of fluid out of the peritoneum, predominantly through peritoneal lymphatics. TCUF of water occurs via the small pores in the peritoneal membrane and the ultrasmall transcellular water channels (aquaporin-1). As mentioned above, the ultrasmall pores contribute as much as 40 percent to the total filtered volume [
         <a href="#rid15">
          15,16
         </a>
         ].
        </p>
        <p>
         The TCUF rate is determined by the net difference of osmotic and hydraulic pressures and the ultrafiltration coefficient of the peritoneal membrane, and is governed by Starling's law. Thus the TCUF rate is equal to:
        </p>
        <div class="formulaContainer">
         <div class="formula">
          <p>
           UFC x (Δ hydraulic pressure - Δ osmotic pressure)
          </p>
         </div>
        </div>
        <p>
         which can be expressed as:
        </p>
        <div class="formulaContainer">
         <div class="formula">
          <p>
           UFC x [(Pcap - Pperit) - (Δπ + sΔO)]
          </p>
         </div>
        </div>
        <p>
         where UFC is peritoneal ultrafiltration coefficient, which is determined by the peritoneal surface area and its hydraulic permeability; Δπ is the oncotic or colloid osmotic pressure gradient; s is the reflection coefficient,; ΔO is the crystalloid osmotic pressure gradient (primarily determined by glucose); and cap and perit refer to values in the capillary and peritoneal fluid, respectively.
        </p>
        <p>
         The intraperitoneal pressure (Pperit) is the major determinant of the hydraulic pressure gradient across the peritoneal membrane. The intraperitoneal pressure is directly dependent upon the instilled dialysate volume [
         <a href="#rid39">
          39
         </a>
         ]. It is also influenced by posture, being approximately 2 to 8 mmHg when supine [
         <a href="#rid40">
          40,41
         </a>
         ], but as high as 20 mmHg in the upright position (eg, walking) [
         <a href="#rid40">
          40
         </a>
         ]. In one study, for example, a 10 mmHg elevation in intraperitoneal pressure reduced net ultrafiltration by 1.1 mL/min due both to reduced TCUF and increased lymphatic absorption [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p>
         The peritoneal capillary colloid osmotic pressure in peritoneal dialysis patients is approximately 21 mmHg [
         <a href="#rid42">
          42
         </a>
         ]. Dialysate glucose is the major determinant of the crystalloid component of osmotic pressure. During CAPD, mean values for the osmotic reflection coefficient of glucose are reported as being quite low (approximately 0.02 to 0.05) [
         <a href="#rid35">
          35,43-46
         </a>
         ]. This value is dependent upon the pore size in the peritoneal membrane. The reflection coefficient for glucose is 1 (ie, no transport) across the ultrasmall pores but approaches 0 (ie, unrestricted transport) across the large pores.
        </p>
        <p>
         The small-solute component of the osmotic pressure gradient is maximal at the start of the dwell and dissipates with time as the dialysate glucose concentration falls due to both absorption into the systemic circulation and dilution by ultrafiltration; the net effect is that the maximum TCUF occurs at the start of the dwell [
         <a href="#rid47">
          47
         </a>
         ]. The mean TCUF for a four-hour dwell with glucose varies with the glucose concentration, being 1 to 1.2 mL/min for 1.36 percent glucose [
         <a href="#rid48">
          48,49
         </a>
         ] and 3.4 mL/min for 3.86 percent glucose [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p>
         The peritoneal membrane is relatively impermeable to large molecules, such as proteins and the glucose polymer
         <a class="drug drug_general" data-topicid="8769" href="/z/d/drug information/8769.html" rel="external">
          icodextrin
         </a>
         (
         <a class="graphic graphic_figure graphicRef75224" href="/z/d/graphic/75224.html" rel="external">
          figure 1
         </a>
         ). When such solutes are present in the dialysate, there is a net fluid flow into the dialysate, a process termed colloid osmosis, which is similar to the effect of plasma proteins to keep fluid in the vascular space. Such solutions utilize the small-pore system for fluid transport. The pressure gradient exerted by these solutions is higher than the commonly used 1.5 percent glucose-based dialysis solutions (even though they are isosmolar) but lower than 4.25 percent glucose-based solutions.
        </p>
        <p>
         The main advantage of using such colloid solutions is a slower loss of gradient dissipation compared with that due to the absorption of glucose. This property provides the rationale for the use of 7.5 percent
         <a class="drug drug_general" data-topicid="8769" href="/z/d/drug information/8769.html" rel="external">
          icodextrin
         </a>
         solutions for inducing TCUF. The absorption of icodextrin is only approximately 20 percent during an eight-hour exchange, allowing ultrafiltration to be maintained over at least 12 hours [
         <a href="#rid42">
          42,49-51
         </a>
         ]. The mean ultrafiltration rate obtained by such colloid osmosis is between 1.4 to 2.3 mL/min [
         <a href="#rid50">
          50,52
         </a>
         ]. In a randomized, controlled trial, isosmolar icodextrin (282 mosmol/kg) produced 3.5 times more ultrafiltration at eight hours and 5.5 times more at 12 hours than conventional 1.36 percent glucose dialysate (346 mosmol/kg) and was of equivalent efficacy to hypertonic 3.86 percent glucose (484 mosmol/kg) [
         <a href="#rid50">
          50
         </a>
         ]. Icodextrin has been approved by the US Food and Drug Administration (FDA).
        </p>
        <p>
         At all times and with all solutions, TCUF is counterbalanced by peritoneal reabsorption, the main routes of reabsorption being via the lymphatics and back-filtration by colloid osmosis. The lymphatic absorption rate varies directly with the intraperitoneal pressure, being higher with higher pressures [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h1">
          CLINICAL CORRELATES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The preceding discussion on solute clearance and ultrafiltration assumes significance when considering the common clinical problem of ultrafiltration failure. The frequency of this problem increases with time [
         <a href="#rid53">
          53
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1973.html" rel="external">
          "Inadequate solute clearance in peritoneal dialysis"
         </a>
         .)
        </p>
        <p>
         Patients with ultrafiltration failure are typically evaluated with a peritoneal equilibration test (PET) (see
         <a class="medical medical_review" href="/z/d/html/1972.html" rel="external">
          "Peritoneal equilibration test"
         </a>
         ). There are four major causes of ultrafiltration failure:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Large peritoneal vascular surface area, leading to significant glucose absorption
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Impaired aquaporin-1-mediated water transport
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Increased lymphatic absorption
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Peritoneal adhesions, leading to a small peritoneal vascular surface area
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Large or small peritoneal vascular surface area
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most common type of ultrafiltration failure is associated with high dialysate-to-plasma ratios of small-molecular-weight solutes and is presumably due to an increase in peritoneal vascular surface area [
         <a href="#rid53">
          53,54
         </a>
         ]. Although a higher water transport rate is achievable with a large surface area, the concomitant increase in absorption of glucose dissipates the osmotic gradient relatively early, resulting in loss of ultrafiltration  (
         <a class="graphic graphic_figure graphicRef62604" href="/z/d/graphic/62604.html" rel="external">
          figure 2
         </a>
         ). There is no uniform agreement as to what causes high permeability [
         <a href="#rid55">
          55
         </a>
         ]. Most believe it is due to larger surface area; however, there may be other causes that are not well defined, such as increased blood flow during an episode of acute peritonitis. This abnormality is called type 1 membrane failure, and these patients are called rapid transporters [
         <a href="#rid53">
          53
         </a>
         ]. The rate of this rapid transport increases over time  (
         <a class="graphic graphic_figure graphicRef64191" href="/z/d/graphic/64191.html" rel="external">
          figure 3
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/1862.html" rel="external">
          "Rapid transporters on maintenance peritoneal dialysis"
         </a>
         .)
        </p>
        <p>
         Conversely, the presence of vasculopathy, such as due to deposition of advanced glycosylated end products in the peritoneal microcirculation, can adversely impact net ultrafiltration. This may be due to the reduction of hydrostatic pressure leading to decreased small pore fluid transport [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p>
         Type 2 failure, on the other hand, is associated with reductions in both solute transport and ultrafiltration due to a small peritoneal vascular surface area. This disorder is rare, often occurring in conjunction with sclerosing encapsulating peritonitis [
         <a href="#rid57">
          57
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1973.html" rel="external">
          "Inadequate solute clearance in peritoneal dialysis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Impaired aquaporin-1-mediated water transport
         </span>
         <span class="headingEndMark">
          —
         </span>
         Impairment in aquaporin-1 (ultrasmall-pore) expression and, more often, function can contribute to ultrafiltration failure. Constant exposure to glucose may eventually lead to peritoneal neoangiogenesis (similar to retinal neoangiogenesis in diabetics) [
         <a href="#rid58">
          58
         </a>
         ], leading to both increased peritoneal vascular surface area and transcellular glycosylation of aquaporin-1. The prevalence of impaired aquaporin-1-mediated water transport as a cause of ultrafiltration failure is not known but is probably very low.
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h3">
          Assessment of aquaporin-1 function
         </span>
         <span class="headingEndMark">
          —
         </span>
         As mentioned above, the dialysate concentration of sodium falls during the initial phase of a hypertonic dwell, followed by a gradual increase [
         <a href="#rid30">
          30,31
         </a>
         ]. The initial fall in sodium concentration, which is known as sodium sieving, results from selective transcellular water transport through the water-selective aquaporin-1 pores, lowering the dialysate sodium concentration by dilution [
         <a href="#rid32">
          32
         </a>
         ]. Thus, the extent of sodium sieving during a hypertonic exchange can provide an estimate of the overall function of these water channels and aquaporin-1 function  (
         <a class="graphic graphic_figure graphicRef67695" href="/z/d/graphic/67695.html" rel="external">
          figure 4
         </a>
         ).
        </p>
        <p>
         The net ultrafiltration obtained during the first two hours of an exchange with 4.25 percent glucose is compared with 1.5 percent glucose. This difference becomes smaller with impairment of aquaporin-1-mediated transcapillary ultrafiltration (TCUF) [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
         Several direct methods to assess free water transport have been described. These include quantification of free water transport from a single, standard peritoneal function test and by using a 4.25 percent mini PET (one hour) [
         <a href="#rid59">
          59,60
         </a>
         ].
        </p>
        <p>
         Ultrafiltration in patients with impaired aquaporin-1 function occurs via nonchannel-mediated pathways, which, as mentioned above, are responsible for approximately 60 percent of water transport across the peritoneal membrane [
         <a href="#rid15">
          15,16
         </a>
         ]. Ultrafiltration can be enhanced in this setting by using
         <a class="drug drug_general" data-topicid="8769" href="/z/d/drug information/8769.html" rel="external">
          icodextrin
         </a>
         in long-dwell exchanges. Alternatively, 4.25 percent glucose exchanges with short dwell times may be helpful to some extent.
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Increased lymphatic absorption
         </span>
         <span class="headingEndMark">
          —
         </span>
         A decrease in net ultrafiltration due to enhanced lymphatic absorption (normally accounting for 10 to 20 percent of fluid reabsorption [
         <a href="#rid61">
          61
         </a>
         ]) can occur in association with a large peritoneal vascular surface area. In such a setting, all measures that are utilized to enhance ultrafiltration should be instituted, including short cycle times, high glucose concentrations, and use of supine dialysis (net ultrafiltration in the supine position is approximately 16 percent higher due largely to a lower intraperitoneal pressure) [
         <a href="#rid62">
          62
         </a>
         ]. Macromolecule, albumin, or hemoglobin absorption from the peritoneal cavity is increased in patients with increased lymphatic absorption [
         <a href="#rid47">
          47
         </a>
         ]. Increased duration of peritoneal dialysis does not appear to enhance lymphatic absorption [
         <a href="#rid61">
          61
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H104937225">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112932.html" rel="external">
          "Society guideline links: Dialysis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10255146">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The peritoneal barrier is composed of three layers, including the peritoneal mesothelium, interstitium, and the capillary endothelium. According to the three-pore model of solute transport, the capillary endothelium contains three different-sized pores, which are size selective in restricting solute transport. (See
         <a class="local">
          'General principles of transport across the peritoneal membrane'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Aquaporin-1 is the smallest sized pore and is responsible for almost 40 percent of free water transport across the peritoneal membrane. (See
         <a class="local">
          'Aquaporin-1 and water transport'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The transport of different solutes across the peritoneal membrane is based on diffusion and convection. (See
         <a class="local">
          'Solute transport'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The transcapillary ultrafiltration (TCUF) rate is determined by the net pressure gradient, as well as by peritoneal membrane characteristics, and is determined by Starling’s law. Both crystalloids and/or colloid-based dialysis solutions may be used to provide the required osmotic or oncotic gradients across the peritoneal membrane. (See
         <a class="local">
          'Fluid transport'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The rate of solute transport varies between individuals, which may have therapeutic implications for dialysis adequacy as well as fluid overload. (See
         <a class="local">
          'Clinical correlates'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ultrafiltration failure may be a result of alterations in the vascular surface area (larger vascular surface area makes more pores available for transport), which leads to the rapid dissipation of glucose gradient across the membrane and fluid retention. Selective loss of aquaporin-1 function and other factors can also lead to ultrafiltration failure. The cause of ultrafiltration failure can often be determined by conducting special studies on the peritoneal membrane. (See
         <a class="local">
          'Clinical correlates'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Khanna R. Solute and Water Transport in Peritoneal Dialysis: A Case-Based Primer. Am J Kidney Dis 2017; 69:461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Esperanca MJ, Collins DL. Peritoneal dialysis efficiency in relation to body weight. J Pediatr Surg 1966; 1:162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pawlaczyk K, Kuzlan M, Wieczorowska-Tobis K, et al. Species-dependent topography of the peritoneum. Adv Perit Dial 1996; 12:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flessner MF. Small-solute transport across specific peritoneal tissue surfaces in the rat. J Am Soc Nephrol 1996; 7:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fox JR, Wayland H. Interstitial diffusion of macromolecules in the rat mesentery. Microvasc Res 1979; 18:255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rippe B, Venturoli D, Simonsen O, de Arteaga J. Fluid and electrolyte transport across the peritoneal membrane during CAPD according to the three-pore model. Perit Dial Int 2004; 24:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waniewski J, Debowska M, Lindholm B. How accurate is the description of transport kinetics in peritoneal dialysis according to different versions of the three-pore model? Perit Dial Int 2008; 28:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rippe B. A three-pore model of peritoneal transport. Perit Dial Int 1993; 13 Suppl 2:S35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pannekeet MM, Mulder JB, Weening JJ, et al. Demonstration of aquaporin-CHIP in peritoneal tissue of uremic and CAPD patients. Perit Dial Int 1996; 16 Suppl 1:S54.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rippe B, Carlsson O. Role of transcellular water channels in peritoneal dialysis. Perit Dial Int 1999; 19 Suppl 2:S95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marples D. Aquaporins: roles in renal function and peritoneal dialysis. Perit Dial Int 2001; 21:212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee MD, King LS, Agre P. The aquaporin family of water channel proteins in clinical medicine. Medicine (Baltimore) 1997; 76:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nielsen S, Kwon TH, Christensen BM, et al. Physiology and pathophysiology of renal aquaporins. J Am Soc Nephrol 1999; 10:647.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akiba T, Ota T, Fushimi K, et al. Water channel AQP1, 3, and 4 in the human peritoneum and peritoneal dialysate. Adv Perit Dial 1997; 13:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rippe B, Stelin G. Simulations of peritoneal solute transport during CAPD. Application of two-pore formalism. Kidney Int 1989; 35:1234.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang B, Folkesson HG, Yang J, et al. Reduced osmotic water permeability of the peritoneal barrier in aquaporin-1 knockout mice. Am J Physiol 1999; 276:C76.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ni J, Verbavatz JM, Rippe A, et al. Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis. Kidney Int 2006; 69:1518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parikova A, Smit W, Zweers MM, et al. Free water transport, small pore transport and the osmotic pressure gradient. Nephrol Dial Transplant 2008; 23:2350.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Devuyst O, Yool AJ. Aquaporin-1: new developments and perspectives for peritoneal dialysis. Perit Dial Int 2010; 30:135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yool AJ, Morelle J, Cnops Y, et al. AqF026 is a pharmacologic agonist of the water channel aquaporin-1. J Am Soc Nephrol 2013; 24:1045.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henderson LW, Nolph KD. Altered permeability of the peritoneal membrane after using hypertonic peritoneal dialysis fluid. J Clin Invest 1969; 48:992.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lindholm B, Werynski A, Bergström J. Kinetics of peritoneal dialysis with glycerol and glucose as osmotic agents. ASAIO Trans 1987; 33:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lysaght MJ, Hallett MD, Farrell PC. Evolution of transport theory in CAPD. Clin Nephrol 1988; 30 Suppl 1:S34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krediet RT, Boeschoten EW, Zuyderhoudt FM, Arisz L. The relationship between peritoneal glucose absorption and body fluid loss by ultrafiltration during continuous ambulatory peritoneal dialysis. Clin Nephrol 1987; 27:51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Struijk DG, Krediet RT, Koomen GC, et al. Indirect measurement of lymphatic absorption with inulin in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int 1990; 10:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krediet RT, Struijk DG, Boeschoten EW, et al. Measurement of intraperitoneal fluid kinetics in CAPD patients by means of autologous haemoglobin. Neth J Med 1988; 33:281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paniagua R, Ventura Mde J, Rodríguez E, et al. Impact of fill volume on peritoneal clearances and cytokine appearance in peritoneal dialysis. Perit Dial Int 2004; 24:156.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Renkin EM. Relation of capillary morphology to transport of fluid and large molecules: a review. Acta Physiol Scand Suppl 1979; 463:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krediet RT, Struijk DG, Koomen GC, et al. The disappearance of macromolecules from the peritoneal cavity during continuous ambulatory peritoneal dialysis (CAPD) is not dependent on molecular size. Perit Dial Int 1990; 10:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nolph KD, Twardowski ZJ, Popovich RP, Rubin J. Equilibration of peritoneal dialysis solutions during long-dwell exchanges. J Lab Clin Med 1979; 93:246.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang T, Waniewski J, Heimbürger O, et al. A quantitative analysis of sodium transport and removal during peritoneal dialysis. Kidney Int 1997; 52:1609.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raja RM, Cantor RE, Boreyko C, et al. Sodium transport during ultrafiltration peritoneal dialysis. Trans Am Soc Artif Intern Organs 1972; 18:429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nolph KD, Hano JE, Teschan PE. Peritoneal sodium transport during hypertonic peritoneal dialysis. Physiologic mechanisms and clinical implications. Ann Intern Med 1969; 70:931.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heimbürger O, Waniewski J, Werynski A, Lindholm B. A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 1992; 41:1320.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Imholz AL, Koomen GC, Struijk DG, et al. Fluid and solute transport in CAPD patients using ultralow sodium dialysate. Kidney Int 1994; 46:333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Merchant MR, Hutchinson AJ, Butler SJ, et al. Calcium, magnesium mass transfer and lactate balance study in CAPD patients with reduced calcium/magnesium and high lactate dialysis fluid. Adv Perit Dial 1992; 8:365.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martis L, Serkes KD, Nolph KD. Calcium carbonate as a phosphate binder: is there a need to adjust peritoneal dialysate calcium concentrations for patients using CaCO3? Perit Dial Int 1989; 9:325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uribarri J, Buquing J, Oh MS. Acid-base balance in chronic peritoneal dialysis patients. Kidney Int 1995; 47:269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Twardowski ZJ, Prowant BF, Nolph KD, et al. High volume, low frequency continuous ambulatory peritoneal dialysis. Kidney Int 1983; 23:64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Twardowski ZJ, Khanna R, Nolph KD, et al. Intraabdominal pressures during natural activities in patients treated with continuous ambulatory peritoneal dialysis. Nephron 1986; 44:129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Imholz AL, Koomen GC, Struijk DG, et al. Effect of an increased intraperitoneal pressure on fluid and solute transport during CAPD. Kidney Int 1993; 44:1078.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ho-dac-Pannekeet MM, Schouten N, Langendijk MJ, et al. Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 1996; 50:979.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rippe B, Perry MA, Granger DN. Permselectivity of the peritoneal membrane. Microvasc Res 1985; 29:89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krediet RT, Imholz AL, Struijk DG, et al. Ultrafiltration failure in continuous ambulatory peritoneal dialysis. Perit Dial Int 1993; 13 Suppl 2:S59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zakaria ER, Rippe B. Osmotic barrier properties of the rat peritoneal membrane. Acta Physiol Scand 1993; 149:355.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leypoldt JK. Interpreting peritoneal membrane osmotic reflection coefficients using a distributed model of peritoneal transport. Adv Perit Dial 1993; 9:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mactier RA, Khanna R, Twardowski Z, et al. Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis. J Clin Invest 1987; 80:1311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Imholz AL, Koomen GC, Struijk DG, et al. Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD. Kidney Int 1993; 43:1339.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mistry CD, Gokal R. Optimal use of glucose polymer (icodextrin) in peritoneal dialysis. Perit Dial Int 1996; 16 Suppl 1:S104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mistry CD, Gokal R, Peers E. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int 1994; 46:496.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rippe B, Levin L. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD. Kidney Int 2000; 57:2546.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Douma CE, Hiralall JK, de Waart DR, et al. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells. Kidney Int 1998; 53:1014.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heimbürger O, Waniewski J, Werynski A, et al. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 1990; 38:495.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pannekeet MM, Imholz AL, Struijk DG, et al. The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 1995; 48:866.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pletinck A, Vanholder R, Veys N, Van Biesen W. Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions. Nat Rev Nephrol 2012; 8:542.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krediet RT, van Diepen ATN, Coester AM, Struijk DG. Peritoneal vasculopathy in the pathophysiology of long-term ultrafiltration failure: A hypothesis based on clinical observations . Clin Nephrol 2019; 91:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krediet RT, Struijk DG, Boeschoten EW, et al. The time course of peritoneal transport kinetics in continuous ambulatory peritoneal dialysis patients who develop sclerosing peritonitis. Am J Kidney Dis 1989; 13:299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krediet RT. Evaluation of peritoneal membrane integrity. J Nephrol 1997; 10:238.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smit W, Struijk DG, Ho-Dac-Pannekeet MM, Krediet RT. Quantification of free water transport in peritoneal dialysis. Kidney Int 2004; 66:849.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           La Milia V, Di Filippo S, Crepaldi M, et al. Mini-peritoneal equilibration test: A simple and fast method to assess free water and small solute transport across the peritoneal membrane. Kidney Int 2005; 68:840.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michels WM, Zweers MM, Smit W, et al. Does lymphatic absorption change with the duration of peritoneal dialysis? Perit Dial Int 2004; 24:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Imholz AL, Koomen GC, Voorn WJ, et al. Day-to-day variability of fluid and solute transport in upright and recumbent positions during CAPD. Nephrol Dial Transplant 1998; 13:146.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 1878 Version 27.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28111028" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Solute and Water Transport in Peritoneal Dialysis: A Case-Based Primer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Peritoneal dialysis efficiency in relation to body weight
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8865861" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Species-dependent topography of the peritoneum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8785391" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Small-solute transport across specific peritoneal tissue surfaces in the rat.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/491987" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Interstitial diffusion of macromolecules in the rat mesentery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15104333" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Fluid and electrolyte transport across the peritoneal membrane during CAPD according to the three-pore model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18178948" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : How accurate is the description of transport kinetics in peritoneal dialysis according to different versions of the three-pore model?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8399608" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : A three-pore model of peritoneal transport.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8728163" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Demonstration of aquaporin-CHIP in peritoneal tissue of uremic and CAPD patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10406501" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Role of transcellular water channels in peritoneal dialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11330571" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Aquaporins: roles in renal function and peritoneal dialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9193450" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : The aquaporin family of water channel proteins in clinical medicine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10073616" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Physiology and pathophysiology of renal aquaporins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9360641" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Water channel AQP1, 3, and 4 in the human peritoneum and peritoneal dialysate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2770105" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Simulations of peritoneal solute transport during CAPD. Application of two-pore formalism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9886922" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Reduced osmotic water permeability of the peritoneal barrier in aquaporin-1 knockout mice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16508653" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17984106" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Free water transport, small pore transport and the osmotic pressure gradient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20200365" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Aquaporin-1: new developments and perspectives for peritoneal dialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23744886" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : AqF026 is a pharmacologic agonist of the water channel aquaporin-1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5771199" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Altered permeability of the peritoneal membrane after using hypertonic peritoneal dialysis fluid.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3828158" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Kinetics of peritoneal dialysis with glycerol and glucose as osmotic agents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3180532" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Evolution of transport theory in CAPD.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3829478" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : The relationship between peritoneal glucose absorption and body fluid loss by ultrafiltration during continuous ambulatory peritoneal dialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2085599" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Indirect measurement of lymphatic absorption with inulin in continuous ambulatory peritoneal dialysis (CAPD) patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3221948" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Measurement of intraperitoneal fluid kinetics in CAPD patients by means of autologous haemoglobin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15119636" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Impact of fill volume on peritoneal clearances and cytokine appearance in peritoneal dialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/382747" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Relation of capillary morphology to transport of fluid and large molecules: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1707684" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : The disappearance of macromolecules from the peritoneal cavity during continuous ambulatory peritoneal dialysis (CAPD) is not dependent on molecular size.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/429837" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Equilibration of peritoneal dialysis solutions during long-dwell exchanges.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9407507" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : A quantitative analysis of sodium transport and removal during peritoneal dialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4679898" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Sodium transport during ultrafiltration peritoneal dialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5783428" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Peritoneal sodium transport during hypertonic peritoneal dialysis. Physiologic mechanisms and clinical implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1614047" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : A quantitative description of solute and fluid transport during peritoneal dialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7967344" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Fluid and solute transport in CAPD patients using ultralow sodium dialysate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1361824" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Calcium, magnesium mass transfer and lactate balance study in CAPD patients with reduced calcium/magnesium and high lactate dialysis fluid.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2488389" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Calcium carbonate as a phosphate binder: is there a need to adjust peritoneal dialysate calcium concentrations for patients using CaCO3?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7731157" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Acid-base balance in chronic peritoneal dialysis patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6834695" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : High volume, low frequency continuous ambulatory peritoneal dialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3774076" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Intraabdominal pressures during natural activities in patients treated with continuous ambulatory peritoneal dialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8264138" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Effect of an increased intraperitoneal pressure on fluid and solute transport during CAPD.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8872974" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Peritoneal transport characteristics with glucose polymer based dialysate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2580217" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Permselectivity of the peritoneal membrane.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8399673" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Ultrafiltration failure in continuous ambulatory peritoneal dialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8310840" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Osmotic barrier properties of the rat peritoneal membrane.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8105949" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Interpreting peritoneal membrane osmotic reflection coefficients using a distributed model of peritoneal transport.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3680499" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8315948" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8728173" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Optimal use of glucose polymer (icodextrin) in peritoneal dialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7967363" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10844624" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9551412" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2232493" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7474677" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22777203" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30431432" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Peritoneal vasculopathy in the pathophysiology of long-term ultrafiltration failure: A hypothesis based on clinical observations .
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2705448" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : The time course of peritoneal transport kinetics in continuous ambulatory peritoneal dialysis patients who develop sclerosing peritonitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9364314" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Evaluation of peritoneal membrane integrity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15253742" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Quantification of free water transport in peritoneal dialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16014064" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Mini-peritoneal equilibration test: A simple and fast method to assess free water and small solute transport across the peritoneal membrane.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15335148" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Does lymphatic absorption change with the duration of peritoneal dialysis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9481731" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Day-to-day variability of fluid and solute transport in upright and recumbent positions during CAPD.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
